PhaseWell Research Partners with Bio Behavioral Health to Expand Neuropsychiatric Clinical Trial Access
核心洞察
PhaseWell Research (搜索) has partnered with Bio Behavioral Health (搜索) to strengthen its national network and enhance capabilities in neurologic and psychiatric research areas.
The collaboration aims to expand access to clinical trials for neuropsychiatric patients while supporting sponsors with reliable enrollment and operational excellence.
Bio Behavioral Health (搜索) brings deep expertise from conducting over 200 clinical trials since 1987 across various CNS indications including depression (搜索), bipolar disorder (搜索), ADHD (搜索), and Alzheimer's disease (搜索).
PhaseWell Research (搜索), a national clinical research site company, has announced a strategic partnership with Bio Behavioral Health (搜索) (BBH), a leading central nervous system (搜索) (CNS) research site specializing in neurologic and psychiatric disorders. The collaboration is designed to address the growing unmet medical needs in neuropsychiatric research while expanding patient access to clinical trials.
Strategic Expansion in CNS Research
The partnership significantly strengthens PhaseWell's national footprint and advances community-based research in CNS therapeutic areas. Based in Nashville, Tennessee, PhaseWell Research (搜索) focuses on increasing clinical trial participation by enabling research within trusted, high-performing sites and community practices nationwide.
Bio Behavioral Health (搜索), headquartered in Toms River, New Jersey, brings substantial expertise in conducting clinical trials within community settings. The organization has been advancing mental and behavioral health care since its founding in 1987, having conducted more than 200 clinical trials across a broad range of behavioral health and CNS indications.
Addressing Critical Medical Needs
"Neuropsychiatric disorders (搜索) represent a critical and growing area of unmet need in the United States, but the medical science coming down the pike is potentially game-changing for this patient population," said Carsten Bick, Chief Executive Officer of PhaseWell Research (搜索). "By combining PhaseWell's national platform with BBH's expertise and community reach within the therapeutic area, we are improving our position to increase patient access to this incredibly important next generation of therapeutics."
The partnership addresses the increasing clinical and societal need for neuropsychiatric research, with BBH's expertise spanning multiple conditions including depression (搜索), bipolar disorder (搜索), ADHD (搜索), Alzheimer's disease (搜索), Parkinson's disease (搜索), schizophrenia (搜索), post-traumatic stress disorder (搜索), and anxiety (搜索).
Enhanced Capabilities and Reach
Through this collaboration, PhaseWell and BBH will expand access to clinical research opportunities for patients while supporting sponsors with reliable enrollment, operational excellence, and high-integrity data. BBH's approach emphasizes patient-centered care, rigorous data quality, and efficient study execution within real-world clinical settings.
"Joining PhaseWell Research (搜索) allows us to scale our impact while staying true to our mission of delivering compassionate, community-based neuropsychiatric research," said Dr. Ashok Patel, founder and leading principal investigator at Bio Behavioral Health (搜索). "Together, we can broaden access to clinical trials for patients, strengthen partnerships with sponsors and CROs, and continue advancing high-quality research that meaningfully contributes to the advancement of medicine in our space."
Proven Track Record
PhaseWell brings extensive experience to the partnership, having completed more than 1,800 clinical trials and contributed to the approval of over 150 therapies. The company delivers comprehensive Phase I–IV clinical trial services across multiple therapeutic areas, including oncology, CNS, cardiovascular/metabolic, and dermatology.
The partnership builds on PhaseWell's foundation of trusted research organizations with longstanding reputations for excellence across complex therapeutic areas. Bio Behavioral Health (搜索) is widely recognized for its commitment to ethical research practices, strong patient engagement, and reliable execution of clinical studies within real-world clinical settings.